<p>Mice were injected intraperitoneally with Zn, atRA or a combination of both compounds. Twenty-four hours after the last dose, the mice were infected intravenously with 10<sup>4</sup>/100 μl per mouse. CFU was measured in the liver and spleen 48 h after infection. The experiment was performed three times with four mice per group each time. Control mice received corn oil alone. Data are mean ± SD values of 12 mice per group. Statistically significant differences, compared with each group, are indicated by asterisks.</p
<p>(A) QRT-PCR analysis of liver mRNA from CCl<sub>4</sub>-treated mice for Tβ4 (n = 4 mice / group)...
<p>Groups of mice were vaccinated with BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-Control (10<sup>7<...
<p>Different parameters were evaluated in WT and Nr4a1<sup>-/-</sup> mice at day 21 pi. Liver Ly6C<s...
<p>Doses were given intraperitoneally for 7 intradays and 6 consecutive days, respectively (<a href=...
<p>Panel A shows the administration procedure. At the end of atRA and Zn administration, mice were i...
<p>Mice were infected with 1×10<sup>5</sup> CFU ActA-Lm–OVA alone, or in combination with increasing...
<p>Infected wild type (WT) and CCR2-DTR mice were treated with DT beginning at week 6 of infection, ...
<p>(<b>A</b>) Lm burdens from C57BL/6 (B6) mice treated with control (IgG2a) or NK1.1<sup>+</sup> ce...
<p>Immunosuppressed, Pc-infected mice were treated with vehicle control 8% DMSO, ATRA, or TMP-SMX fo...
<p>(A) C57BL/6 Cyld<sup>−/−</sup> (n = 10) and WT (n = 10) mice were infected i.v. with 5×10<sup>5</...
<p>(A) Mice were treated with simvastatin at 10 and 20 mg/kg/day or with vehicle control by daily in...
<p><b>(A)</b> Liver Ly6C<sup>+</sup> monocytes (Ly6C<sup>+</sup> Mo) and MHC-II<sup>- to lo</sup> Ly...
<p>Wt and CXCR6<sup>GFP/GFP</sup> mice were infected with 1×10<sup>4 </sup><i>Lm</i> i.v. and lister...
<p>The mice were injected intranasally (i.n.) with 2x10<sup>7</sup> CFU of mCherry-Br <i>B</i>. <i>m...
<p>SD group: control mice receiving a standard diet (SD) plus placebo; HFD group: obese mice receivi...
<p>(A) QRT-PCR analysis of liver mRNA from CCl<sub>4</sub>-treated mice for Tβ4 (n = 4 mice / group)...
<p>Groups of mice were vaccinated with BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-Control (10<sup>7<...
<p>Different parameters were evaluated in WT and Nr4a1<sup>-/-</sup> mice at day 21 pi. Liver Ly6C<s...
<p>Doses were given intraperitoneally for 7 intradays and 6 consecutive days, respectively (<a href=...
<p>Panel A shows the administration procedure. At the end of atRA and Zn administration, mice were i...
<p>Mice were infected with 1×10<sup>5</sup> CFU ActA-Lm–OVA alone, or in combination with increasing...
<p>Infected wild type (WT) and CCR2-DTR mice were treated with DT beginning at week 6 of infection, ...
<p>(<b>A</b>) Lm burdens from C57BL/6 (B6) mice treated with control (IgG2a) or NK1.1<sup>+</sup> ce...
<p>Immunosuppressed, Pc-infected mice were treated with vehicle control 8% DMSO, ATRA, or TMP-SMX fo...
<p>(A) C57BL/6 Cyld<sup>−/−</sup> (n = 10) and WT (n = 10) mice were infected i.v. with 5×10<sup>5</...
<p>(A) Mice were treated with simvastatin at 10 and 20 mg/kg/day or with vehicle control by daily in...
<p><b>(A)</b> Liver Ly6C<sup>+</sup> monocytes (Ly6C<sup>+</sup> Mo) and MHC-II<sup>- to lo</sup> Ly...
<p>Wt and CXCR6<sup>GFP/GFP</sup> mice were infected with 1×10<sup>4 </sup><i>Lm</i> i.v. and lister...
<p>The mice were injected intranasally (i.n.) with 2x10<sup>7</sup> CFU of mCherry-Br <i>B</i>. <i>m...
<p>SD group: control mice receiving a standard diet (SD) plus placebo; HFD group: obese mice receivi...
<p>(A) QRT-PCR analysis of liver mRNA from CCl<sub>4</sub>-treated mice for Tβ4 (n = 4 mice / group)...
<p>Groups of mice were vaccinated with BCG-Gag, BCG-Control, BCGpan-Gag or BCGpan-Control (10<sup>7<...
<p>Different parameters were evaluated in WT and Nr4a1<sup>-/-</sup> mice at day 21 pi. Liver Ly6C<s...